These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 38871123)
1. Reducing the harm associated in treating hyperkalaemia with insulin and dextrose. Abou Sherif S; Katsaiti I; Jebb H; Banh S; Bedi R; Levy J; Thomas D; Ashby D; Corbett R Clin Med (Lond); 2024 Jul; 24(4):100222. PubMed ID: 38871123 [TBL] [Abstract][Full Text] [Related]
2. Iatrogenic hypoglycaemia following glucose-insulin infusions for the treatment of hyperkalaemia. Tee SA; Devine K; Potts A; Javaid U; Razvi S; Quinton R; Roberts G; Leech NJ Clin Endocrinol (Oxf); 2021 Feb; 94(2):176-182. PubMed ID: 32979855 [TBL] [Abstract][Full Text] [Related]
3. Blood glucose reduction in patients treated with insulin and dextrose for hyperkalaemia. Aljabri A; Perona S; Alshibani M; Khobrani M; Jarrell D; Patanwala AE Emerg Med J; 2020 Jan; 37(1):31-35. PubMed ID: 31653693 [TBL] [Abstract][Full Text] [Related]
4. Hypoglycaemia following treatment of hyperkalaemia with insulin and dextrose. Williams PS; Davenport A; Bone JM Postgrad Med J; 1988 Jan; 64(747):30-2. PubMed ID: 3047719 [TBL] [Abstract][Full Text] [Related]
5. Hypoglycaemia due to insulin therapy for the management of hyperkalaemia in hospitalised adults: A scoping review. Chothia MY; Humphrey T; Schoonees A; Chikte UME; Davids MR PLoS One; 2022; 17(5):e0268395. PubMed ID: 35552566 [TBL] [Abstract][Full Text] [Related]
7. Risk factors, prevention and treatment of hypoglycaemia after hyperkalaemia in adult patients using intravenous insulin: An integrative review. Long DS; Kelly MA; Lim SH Int J Nurs Pract; 2023 Feb; 29(1):e13080. PubMed ID: 35859317 [TBL] [Abstract][Full Text] [Related]
8. Potassium binders for chronic hyperkalaemia in people with chronic kidney disease. Natale P; Palmer SC; Ruospo M; Saglimbene VM; Strippoli GF Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013165. PubMed ID: 32588430 [TBL] [Abstract][Full Text] [Related]
9. Current hyperkalemia interventions co-administered with a dextrose 10% solution significantly lower hypoglycemic rates (CHICA-D10). Ibarra F; Fountain C; Fallert T Am J Emerg Med; 2024 Oct; 84():120-123. PubMed ID: 39111100 [TBL] [Abstract][Full Text] [Related]
10. Long-term safety and efficacy of sodium zirconium cyclosilicate for hyperkalaemia in patients with mild/moderate versus severe/end-stage chronic kidney disease: comparative results from an open-label, Phase 3 study. Roger SD; Lavin PT; Lerma EV; McCullough PA; Butler J; Spinowitz BS; von Haehling S; Kosiborod M; Zhao J; Fishbane S; Packham DK Nephrol Dial Transplant; 2021 Jan; 36(1):137-150. PubMed ID: 32030422 [TBL] [Abstract][Full Text] [Related]
11. Sodium Zirconium Cyclosilicate: A Review in Hyperkalaemia. Hoy SM Drugs; 2018 Oct; 78(15):1605-1613. PubMed ID: 30306338 [TBL] [Abstract][Full Text] [Related]
12. Fixed-rate insulin for adult diabetic ketoacidosis is associated with more frequent hypoglycaemia than rate-reduction method: a retrospective cohort study. Lorenson JL; Cusumano MC; Stewart AM; Buhnerkempe MG; Sanghavi D Int J Pharm Pract; 2019 Aug; 27(4):380-385. PubMed ID: 30847977 [TBL] [Abstract][Full Text] [Related]
13. Emergency Potassium Normalization Treatment Including Sodium Zirconium Cyclosilicate: A Phase II, Randomized, Double-blind, Placebo-controlled Study (ENERGIZE). Peacock WF; Rafique Z; Vishnevskiy K; Michelson E; Vishneva E; Zvereva T; Nahra R; Li D; Miller J Acad Emerg Med; 2020 Jun; 27(6):475-486. PubMed ID: 32149451 [TBL] [Abstract][Full Text] [Related]
14. A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia. Fishbane S; Ford M; Fukagawa M; McCafferty K; Rastogi A; Spinowitz B; Staroselskiy K; Vishnevskiy K; Lisovskaja V; Al-Shurbaji A; Guzman N; Bhandari S J Am Soc Nephrol; 2019 Sep; 30(9):1723-1733. PubMed ID: 31201218 [TBL] [Abstract][Full Text] [Related]
15. Management of Hyperkalemia With Insulin and Glucose: Pearls for the Emergency Clinician. Moussavi K; Fitter S; Gabrielson SW; Koyfman A; Long B J Emerg Med; 2019 Jul; 57(1):36-42. PubMed ID: 31084947 [TBL] [Abstract][Full Text] [Related]
16. Do high fasting glucose levels suggest nocturnal hypoglycaemia? The Somogyi effect-more fiction than fact? Choudhary P; Davies C; Emery CJ; Heller SR Diabet Med; 2013 Aug; 30(8):914-7. PubMed ID: 23672623 [TBL] [Abstract][Full Text] [Related]
17. Evaluating Risk Factors for Developing Hypoglycemia During Treatment of Hyperkalemia With Intravenous Regular Insulin. Beard MM; McKenzie JJ; Potter TG; Varney Gill K J Pharm Pract; 2024 Oct; 37(5):1091-1098. PubMed ID: 38178363 [No Abstract] [Full Text] [Related]
18. Efficacy and safety of sodium zirconium cyclosilicate for hyperkalaemia: the randomized, placebo-controlled HARMONIZE-Global study. Zannad F; Hsu BG; Maeda Y; Shin SK; Vishneva EM; Rensfeldt M; Eklund S; Zhao J ESC Heart Fail; 2020 Feb; 7(1):54-64. PubMed ID: 31944628 [TBL] [Abstract][Full Text] [Related]
19. A comparison of insulin doses for treatment of hyperkalaemia in intensive care unit patients with renal insufficiency. Verdier M; DeMott JM; Peksa GD Aust Crit Care; 2022 May; 35(3):258-263. PubMed ID: 34167889 [TBL] [Abstract][Full Text] [Related]
20. Frequency of serum blood glucose monitoring after hyperkalaemia treatment using insulin and dextrose. Aljabri AM; Alsulami SA J Taibah Univ Med Sci; 2022 Feb; 17(1):82-86. PubMed ID: 35140569 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]